Skip to content
FDA.report
Public FDA data
NDC
RxNorm
DailyMed
Applications
GUDID
GMDN
PMA
PMN
MAUDE
Recalls
Search FDA.report
Search
Home
DailyMed
class
c434d77e-d415-4502-8cbb-fb13d57bccdb
SPINOSAD Pharmacologic Class Indexing
Class set ID
c434d77e-d415-4502-8cbb-fb13d57bccdb
Version
2
Effective date
20180813
Type
Indexing - Pharmacologic Class
Mapped DailyMed Labels
#
Label, Manufacturer, Effective table
Label
Manufacturer
Effective
SPL version
These highlights do not include all the information needed to use NATROBA Topical Suspension safely and effectively. See full prescribing information for NATROBA Topical Suspension. NATROBA (spinosad) topical suspension Initial U.S. Approval: 2011
Cipher Pharmaceuticals Inc.
20260304
2
These highlights do not include all the information needed to use Spinosad Topical Suspension safely and effectively. See full prescribing information for Spinosad Topical Suspension. Spinosad Topical Suspension Initial U.S. Approval: 2011
Cipher Pharmaceuticals Inc.
20260304
2
6172e22f-52c4-442f-946d-e17c3f71a4e6
Corteva Inc. | Corteva Agriscience LLC
20260206
2
These highlights do not include all the information needed to use Spinosad Topical Suspension safely and effectively. See full prescribing information for Spinosad Topical Suspension. Spinosad Topical Suspension Initial U.S. Approval: 2011
Allegis Pharmaceuticals, LLC
20251217
9
These highlights do not include all the information needed to use Spinosad Topical Suspension safely and effectively. See full prescribing information for Spinosad Topical Suspension. Spinosad Topical Suspension Initial U.S. Approval: 2011
ParaPRO LLC | Ferndale Laboratories, Inc. | Pharmaceutics International Inc.
20240129
1
These highlights do not include all the information needed to use NATROBA Topical Suspension safely and effectively. See full prescribing information for NATROBA Topical Suspension. NATROBA TM (spinosad) topical suspension Initial U.S. Approval: 2011
ParaPRO LLC | Pharmaceutics International Inc.
20210428
10